Asthma Management: Curtailing Costs and Improving Patient Outcomes

References

• Mannino D M, Homa D M, Pertowski C A, et al. Surveillance for asthma—United States, 1960–1995. Atlanta, GA: Centers for Disease Control and Prevention. MMWR CDC Surveill Sumnt 1998; 47, No. SS-1
   Google Scholar
• Kaliner M. Goals of asthma therapy. Ann Allergy Asthma Immunol 1995; 75: 169
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. National Asthma Education Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH, Bethesda, MD 1997, Publication No. 97–4501
   Google Scholar
• Weiss K B, Gergen P J, Hodgson T A. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862
   PubMed Web of Science ®Google Scholar
• Burt C W, Knapp D E. Ambulatory Care Visits for Asthma: United States. National Center for Health Statistics. 1996; 1993–94
   Google Scholar
• Meza C, Gershwin M E. Why is asthma becoming more of a problem?. Curr Opin Pulm Med 1997; 3: 6
   PubMedGoogle Scholar
• Sly R M. Changing asthma mortality and sales of inhaled bronchodilators and anti asthmatic drugs. Ann Allergy 1994a; 73: 439
   PubMedGoogle Scholar
• Strunk R C, Mrazek D A, Fuhrmann G S, LaBrecque J F. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. A case controlled study. JAMA 1985; 254: 1193
   PubMed Web of Science ®Google Scholar
• Rea H H, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland D C. A case control study of deaths from asthma. Thorax 1986; 41: 833
   PubMed Web of Science ®Google Scholar
• Smith D H, Malone D C, Lawson K A, Okamoto L J, Battista C, Saunders W B. A national estimate of the economic costs of asthma. Am J Resp Crit Care Med 1997; 156: 787
   PubMed Web of Science ®Google Scholar
• Greenberger P A. Preventing the emergence of the $100,000 asthmatic. Medscape Respiratory Care 1998; 2((1)), http://www.medscape.com
   Google Scholar
• O'Brien K P. Asthma in the managed care setting. Curr Opin Pulm Med 1997; 3: 56
   PubMedGoogle Scholar
• Dales R E, Kerr P E, Schweitzer I, Reesor K, Gougeon L, Dickinson G. Asthma management preceding an emergency department visit. Arch Intern Med 1992; 152: 2041
   PubMedGoogle Scholar
• Coventry J A, Weston M S, Collins P M. Emergency room encounters of pediatric patients with asthma: cost comparisons with other treatment settings. J Ambulatory Care Manag 1996; 19: 9
   PubMedGoogle Scholar
• Bousquet J, Yssel H, Vignola A M, Chanez P. New developments in the immunology of asthma, with a focus of mechanisms and treatment. Curr Opin Pulm Med 1997; 3: 42
   PubMedGoogle Scholar
• Morris R J. Asthma. Specific preventive strategies. Postgrad Med 1996; 100: 105
   PubMed Web of Science ®Google Scholar
• Carter P M, Heinly T L, Yates S W, Lieberman P L. Asthma: the irreversible airways disease. J Investig Allergol Clin Immunol 1997; 7: 566
   PubMed Web of Science ®Google Scholar
• McFadden E R, Jr. Evolving concepts in the pathogenesis and management of asthma. Adv Intern Med 1994; 39: 357
   PubMedGoogle Scholar
• Moore R H, Khan A, Dickey B F. Long acting inhaled beta2-agonists in asthma therapy. Chest 1998; 113: 1095
   PubMed Web of Science ®Google Scholar
• Floreani A, Rennard S I. Experimental treatments for asthma. Curr Opin Pulm Med 1997; 3: 30
   PubMedGoogle Scholar
• Reiss T F, Altman L C, Chervinsky P, et al. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma. J Allergy Clin Immunol 1996; 98: 528
   PubMed Web of Science ®Google Scholar
• Spector S L, Smith L J, Glass M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 1994; 150: 618
   PubMed Web of Science ®Google Scholar
• Israel E, Cohn J, Dubé L, Drazen J M. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. JAMA 1996; 275: 931
   PubMed Web of Science ®Google Scholar
• Schwartz H J, Petty T, Dube L M, Swanson L J, Lancaster J F. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group. Arch Intern Med 1998; 158: 141
   PubMedGoogle Scholar
• Suissa S, Dennis R, Ernst P, Sheehy O, Wood-Dauphinee S. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997; 126: 177
   PubMed Web of Science ®Google Scholar
• Singulair Prescribing Information. Merck & Co., West Point, PA 1998
   Google Scholar
• Knorr B, Matz J, Bernstein J A, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. JAMA 1998; 279: 1181
   PubMed Web of Science ®Google Scholar
• Billings J, Kretz S E, Rose R, et al. National Asthma Education and Prevention Program working group report on the financing of asthma care. Am J Respir Crit Care Med 1996; 154: S119
   Web of Science ®Google Scholar
• National Institutes of Health. National Asthma Education Program. Guidelines for the Diagnosis and Management of Asthma. NIH, Bethesda, MD 1991, Publication No. 91–3042
   Google Scholar
• Doerschug K C, Kline J N, Peterson M W. Physician understanding of the 1997 NHLBI asthma guidelines. Paper presented at American Lung Association American Thoracic Society International Conference, Chicago, IL, April, 251998
   Google Scholar
• Emerman C L, Cydulka R K, Skobeloff E. Survey of asthma practice among emergency physicians. Chest 1996; 109: 708
   PubMed Web of Science ®Google Scholar
• Managing asthma care. Business Health 1995; 13((Suppl D))1
   Google Scholar
• Mellins R B, Evans D, Zimmerman B, Clark N M. Patient compliance. Are we wasting our time and don't know it?. Am Rev Respir Dis 1992; 146: 1376
   PubMed Web of Science ®Google Scholar
• Berg J S, Dischler J, Wagner D J, Raia J J, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother 1993; 27: S1
   PubMed Web of Science ®Google Scholar
• Munroe W P, Kunz K, Dalmady-Israel C, Potter L, Schonfeld W H. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19: 113
   PubMed Web of Science ®Google Scholar
• Rohl B J, Meyer L C, Lung C L. An individualized, comprehensive asthma care treatment program. Med Interface 1994; 7: 121–123, 134
   PubMedGoogle Scholar
• Managing critical junctures to improve cost and quality. Business Health 1996; 14((Suppl B))24
   PubMedGoogle Scholar
• Zeiger R S, Heller S, Mellon M H, Wald J, Falkoff R, Schatz M. Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits. J Allergy Clin Immunol 1991; 87: 1160
   PubMed Web of Science ®Google Scholar
• Pauley T R, Magee M J, Cury J D. Pharmacist managed, physician directed asthma management program reduces emergency department visits. Ann Pharmacother 1995; 29: 5
   PubMed Web of Science ®Google Scholar
• Wolle J M, Cwi J. Physician's prevention related practice behaviors in treating adult patients with asthma: results of a national survey. J Asthma 1995; 32: 131
   PubMed Web of Science ®Google Scholar